March 14, 2022
55KRC featured the University of Cincinnati's Dr. Timothy Phoenix on the Simply Medicine program, discussing his research into treatments for diffuse midline glioma, a deadly pediatric brain tumor.
February 4, 2022
Medical Xpress highlighted the work of the University of Cincinnati's Timothy Phoenix and his colleagues who have identified the role of a key gene linked to pediatric diffuse midline gliomas, a deadly brain tumor.
March 23, 2022
The University of Cincinnati's Michael Hegener, PharmD, was featured in a HuffPost article about different health issues pharmacists can help patients with beyond filling prescriptions.
April 29, 2022
The University of Cincinnati's Jill Boone was featured in a Local 12 story on the impact of staffing issues at local pharmacies.
August 17, 2022
The University of Cincinnati's Michael Hegener, PharmD, was a panelist on WVXU's Cincinnati Edition discussing the under-regulated dietary supplements industry.
April 7, 2023
Drug Discovery News highlighted research coauthored by the University of Cincinnati's Timothy Phoenix that found a gene called FOXR2 is abnormally expressed in more than 70% of cancer types sampled and could be a potential target for new treatments.
April 14, 2023
Physics World highlighted research led by the University of Cincinnati's Nalinikanth Kotagiri that shows a proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
April 10, 2023
The University of Cincinnati's Kelly Dobos walked the Wall Street Journal through ingredients in a commercially available foundation from a "clean beauty" brand.
November 15, 2022
The University of Cincinnati's Randall Wickett spoke with Cosmetics Design Asia about the importance of cosmetics industries being able to verify claims about their products and new technology that will allow the industry to do so.
October 26, 2022
The University of Cincinnati's Kelly Dobos was featured in a Washington Post article about the recent recall of more than a dozen dry shampoos due to the possibility they contain “elevated levels” of benzene.